Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodies
- 11 September 2008
- Vol. 380 (2) , 394-401
- https://doi.org/10.1016/j.virol.2008.08.009
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and InfectivityJournal of Virology, 2008
- Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox VaccineJournal of Virology, 2008
- Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Intra-nasal vaccinationVaccine, 2008
- Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesVaccine, 2007
- Vaccinia Virus G9 Protein Is an Essential Component of the Poxvirus Entry-Fusion ComplexJournal of Virology, 2006
- Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal PathwayJournal of Virology, 2006
- The Envelope G3L Protein Is Essential for Entry of Vaccinia Virus into Host CellsJournal of Virology, 2006
- Ligand-induced and nonfusogenic dissolution of a viral membraneProceedings of the National Academy of Sciences, 2006
- Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28L GeneJournal of Virology, 2004
- Vaccinia Virus A28L Gene Encodes an Essential Protein Component of the Virion Membrane with Intramolecular Disulfide Bonds Formed by the Viral Cytoplasmic Redox PathwayJournal of Virology, 2004